BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, Xu F, Wang YL, Li DQ. Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China. World J Gastroenterol 2008; 14(4): 632-635 [PMID: 18203300 DOI: 10.3748/wjg.14.632]
URL: https://www.wjgnet.com/1007-9327/full/v14/i4/632.htm
(0) (0) (7438) (120)
Number Citing Articles
1
Hai‐Rim Shin, Jin‐Kyoung Oh, Eric Masuyer, Maria‐Paula Curado, Veronique Bouvard, Yue‐Yi Fang, Surapon Wiangnon, Banchob Sripa, Sung‐Tae Hong. Epidemiology of cholangiocarcinoma: An update focusing on risk factors. Cancer Science 2010; 101(3) doi: 10.1111/j.1349-7006.2009.01458.x
2
Alina Pascale, Olivier Rosmorduc, Jean-Charles Duclos-Vallée. New epidemiologic trends in cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 2023; 47(9) doi: 10.1016/j.clinre.2023.102223
3
Kyu Sik Jung, Kyeong Hyeon Chun, Gi Hong Choi, Hyae Min Jeon, Hye Sun Shin, Young Nyun Park, Jun Yong Park. Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports. BMC Research Notes 2013; 6(1) doi: 10.1186/1756-0500-6-520
4
Jeffrey S. Chang, Chia-Rung Tsai, Li-Tzong Chen, Fu-Sheng Wang. Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study. PLoS ONE 2013; 8(7) doi: 10.1371/journal.pone.0069981
5
Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco Negro, Christian Trépo. Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection. Clinical Gastroenterology and Hepatology 2010; 8(11) doi: 10.1016/j.cgh.2010.06.032
6
Xiaofei Cheng, Feng Zhao, Dong Chen, Piao Yang, Weixiang Zhong, Xiangming Xu, Weilin Wang. Successful treatment of colorectal liver metastasis harboring intrahepatic cholangiocarcinoma. Medicine 2018; 97(51) doi: 10.1097/MD.0000000000013751
7
Meng Sha, Seogsong Jeong, Xin Wang, Ying Tong, Jie Cao, Han-Yong Sun, Lei Xia, Ning Xu, Zhi-Feng Xi, Jian-Jun Zhang, Xiao-Ni Kong, Qiang Xia. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5420-z
8
Ping Wang, Yu He, Xiaodong Ma, Beiwang Sun, Binyuan Huang, Canhua Zhu, Yanmin Liu. Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma. Medical Science Monitor 2015; 21 doi: 10.12659/MSM.894330
9
Jessica L. Petrick, Jake E. Thistle, Anne Zeleniuch-Jacquotte, Xuehong Zhang, Jean Wactawski-Wende, Alison L. Van Dyke, Meir J. Stampfer, Rashmi Sinha, Howard D. Sesso, Catherine Schairer, Lynn Rosenberg, Thomas E. Rohan, Kim Robien, Mark P. Purdue, Jenny N. Poynter, Julie R. Palmer, Christina C. Newton, Martha S. Linet, Linda M. Liao, I-Min Lee, Jill Koshiol, Cari M. Kitahara, Jonathan N. Hofmann, Barry I. Graubard, Edward Giovannucci, Michael J. Gaziano, Susan M. Gapstur, Neal D. Freedman, Dawn Q. Chong, Andrew T. Chan, Julie E. Buring, Laura Beane E. Freeman, Peter T. Campbell, Katherine A. McGlynn. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. American Journal of Gastroenterology 2018; 113(10) doi: 10.1038/s41395-018-0207-4
10
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms 2013; 6(2) doi: 10.1242/dmm.010561
11
Beihui Xue, Sunjie Wu, Mingyue Zhang, Junjie Hong, Bole Liu, Nina Xu, Qiqiang Zeng, Kun Tang, Xiangwu Zheng. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis. Abdominal Radiology 2021; 46(8) doi: 10.1007/s00261-021-03027-6
12
Miaoyan Wei, Lisheng Lü, Peiyi Lin, Zhisheng Chen, Zhiwei Quan, Zhaohui Tang. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma. Cancer Letters 2016; 379(2) doi: 10.1016/j.canlet.2016.02.038
13
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis. BioMed Research International 2016; 2016 doi: 10.1155/2016/3417976
14
G. L. Tyson, S. Keihanian, H. B. El-Serag. Hilar Cholangiocarcinoma. 2013;  doi: 10.1007/978-94-007-6473-6_2
15
T. Peter Kingham, Victoria G. Aveson, Alice C. Wei, Jason A. Castellanos, Peter J. Allen, Daniel P. Nussbaum, Yinin Hu, Michael I. D'Angelica. Surgical management of biliary malignancy. Current Problems in Surgery 2021; 58(2) doi: 10.1016/j.cpsurg.2020.100854
16
Linchao Ding, Shilong Ning, Weijian Hu, Yadong Xue, Shi’an Yu, Md Sayed Ali Sheikh. [Retracted] Distinctive Metabolism‐Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2022; 2022(1) doi: 10.1155/2022/6595989
17
Umair Mahmood, Ahmed Abbass, Khurum Khan. Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma. Cancer Treatment Reviews 2024; 131 doi: 10.1016/j.ctrv.2024.102851
18
Gary M Clifford. Expanding the list of cancers recognized to be caused by infectious agents. JNCI: Journal of the National Cancer Institute 2024; 116(12) doi: 10.1093/jnci/djae185
19
Shao-Qiang Li, Li-Jian Liang, Yun-Peng Hua, Bao-Gang Peng, Dong Chen, Shun-Jun Fu. Bilateral liver resection for bilateral intrahepatic stones. World Journal of Gastroenterology 2009; 15(29): 3660-3663 doi: 10.3748/wjg.15.3660
20
Min Li, Jinzheng Li, Peizhi Li, Hongyang Li, Tianyi Su, Rongtao Zhu, Jianping Gong. Hepatitis B virus infection increases the risk of cholangiocarcinoma: A meta‐analysis and systematic review. Journal of Gastroenterology and Hepatology 2012; 27(10) doi: 10.1111/j.1440-1746.2012.07207.x
21
Yiqi Wu, Tianzhen Wang, Shengqian Ye, Ran Zhao, Xiaohui Bai, Yingying Wu, Kenji Abe, Xiaoming Jin. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population. Human Pathology 2012; 43(1) doi: 10.1016/j.humpath.2011.04.004
22
Ban Seok Lee, Eun-Cheol Park, Seung Woo Park, Chung Mo Nam, Jaehoon Roh. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: A case-control study in Korea. World Journal of Gastroenterology 2015; 21(2): 502-510 doi: 10.3748/wjg.v21.i2.502
23
Kun-Ming Chan, Chun-Yi Tsai, Chun-Nan Yeh, Ta-Sen Yeh, Wei-Chen Lee, Yi-Yin Jan, Miin-Fu Chen. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0912-x
24
Shun-ichi Ariizumi, Masakazu Yamamoto. Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis. Surgery Today 2015; 45(6) doi: 10.1007/s00595-014-1031-0
25
Seonjeong Woo, Youngun Kim, Sohyun Hwang, Hong Jae Chon. Epidemiology and genomic features of biliary tract cancer and its unique features in Korea. Journal of Liver Cancer 2025; 25(1) doi: 10.17998/jlc.2025.02.27
26
Roongruedee Chaiteerakij, Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Teresa A. Mettler, Zachary S. Fredericksen, Ray W. Kim, Gregory J. Gores, Rosebud O. Roberts, Janet E. Olson, Terry M. Therneau, Lewis R. Roberts. Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk. Hepatology 2013; 57(2) doi: 10.1002/hep.26092
27
Alan W. Hemming. Biliary Tract and Primary Liver Tumors. Surgical Oncology Clinics of North America 2019; 28(4) doi: 10.1016/j.soc.2019.06.012
28
Allyson K. Martínez, Kendal Jensen, Chad Hall, April O'Brien, Laurent Ehrlich, Tori White, Fanyin Meng, Tianhao Zhou, John Greene, Francesca Bernuzzi, Pietro Invernizzi, David E. Dostal, Terry Lairmore, Gianfranco Alpini, Shannon S. Glaser. Nicotine Promotes Cholangiocarcinoma Growth in Xenograft Mice. The American Journal of Pathology 2017; 187(5) doi: 10.1016/j.ajpath.2017.01.011
29
S. Ralphs, S. A. Khan. The role of the hepatitis viruses in cholangiocarcinoma. Journal of Viral Hepatitis 2013; 20(5) doi: 10.1111/jvh.12093
30
In Rae Cho, Sang-Wook Yi, Ja Sung Choi, Jee-Jeon Yi. Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults. Cancers 2022; 14(7) doi: 10.3390/cancers14071709
31
Jessica L. Petrick, Andrea A. Florio, Rohit Loomba, Katherine A. McGlynn. Have incidence rates of liver cancer peaked in the United States?. Cancer 2020; 126(13) doi: 10.1002/cncr.32794
32
学河 朱. Typing, Risk Factors and Related Treatments of Cholangiocarcinoma. Advances in Clinical Medicine 2014; 4(04) doi: 10.12677/ACM.2014.44014
33
C. de Martel, M. Plummer, S. Franceschi. Cholangiocarcinoma: Descriptive epidemiology and risk factors. Gastroentérologie Clinique et Biologique 2010; 34(3) doi: 10.1016/j.gcb.2010.01.008
34
Felice Giuliante, Agostino Maria De Rose, Gennaro Nuzzo. Benign Tumors of the Liver. 2015;  doi: 10.1007/978-3-319-12985-3_10
35
Beihui Xue, Sunjie Wu, Minghua Zheng, Huanchang Jiang, Jun Chen, Zhenghao Jiang, Tian Tian, Yifan Tu, Huanhu Zhao, Xian Shen, Kuvaneshan Ramen, Xiuling Wu, Qiyu Zhang, Qiqiang Zeng, Xiangwu Zheng. Development and Validation of a Radiomic-Based Model for Prediction of Intrahepatic Cholangiocarcinoma in Patients With Intrahepatic Lithiasis Complicated by Imagologically Diagnosed Mass. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.598253
36
Ben-Dong Chen, Wen-Chao Zhao, Jian-Da Dong, Hui Sima. Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissues. Molecular Biology Reports 2014; 41(7) doi: 10.1007/s11033-014-3302-7
37
Ruben R. Plentz, Nisar P. Malek. Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Practice & Research Clinical Gastroenterology 2015; 29(2) doi: 10.1016/j.bpg.2015.02.001
38
Nanna M. Uldall Torp, Simon B. Kristensen, Frank V. Mortensen, Jakob Kirkegård. Cholecystitis and risk of pancreatic, liver, and biliary tract cancer in patients undergoing cholecystectomy. HPB 2020; 22(9) doi: 10.1016/j.hpb.2019.11.012
39
Shinichi Aishima, Tomohiro Iguchi, Nobuhiro Fujita, Akinobu Taketomi, Yoshihiko Maehara, Masazumi Tsuneyoshi, Yoshinao Oda. Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non‐biliary aetiology. Histopathology 2011; 59(5) doi: 10.1111/j.1365-2559.2011.04011.x
40
Yanming Zhou, Yanfang Zhao, Bin Li, Jiyi Huang, Lupeng Wu, Donghui Xu, Jiamei Yang, Jia He. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-289
41
Hao Li, Bin Hu, Zun-Qiang Zhou, Jiao Guan, Zheng-Yun Zhang, Guang-Wen Zhou. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0583-9
42
Rachel M. Lee, Shishir K. Maithel. Approaches and Outcomes to Distal Cholangiocarcinoma. Surgical Oncology Clinics of North America 2019; 28(4) doi: 10.1016/j.soc.2019.06.014
43
Lian-Yuan Tao, Xiao-Dong He, Qiang Qu, Lei Cai, Wei Liu, Li Zhou, Shang-Ming Zhang. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case–control study in China. Liver International 2010; 30(2) doi: 10.1111/j.1478-3231.2009.02149.x
44
Roongruedee Chaiteerakij, Wirichada Pan-ngum, Kittiyod Poovorawan, Ngamphol Soonthornworasiri, Sombat Treeprasertsuk, Kamthorn Phaosawasdi. Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study. World Journal of Gastroenterology 2017; 23(39): 7160-7167 doi: 10.3748/wjg.v23.i39.7160
45
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 2020; 126(11) doi: 10.1002/cncr.32803
46
Shao-Liang Han, Hong-Zhong Zhou, Jun Cheng, Sheng-Hong Lan, Pei-Chen Zhang, Zhe-Jing Chen, Qi-Qiang Zeng. Diagnosis and Surgical Treatment of Intrahepatic Hepatolithiasis Associated Cholangiocarcinoma. Asian Journal of Surgery 2009; 32(1) doi: 10.1016/S1015-9584(09)60001-4
47
Hong-Yang Li, Shi-Ji Zhou, Min Li, Ding Xiong, Akanand Singh, Qing-Xi Guo, Chang-An Liu, Jian-Ping Gong. Diagnosis and Cure Experience of Hepatolithiasis-Associated Intrahepatic Cholangiocarcinoma in 66 Patients. Asian Pacific Journal of Cancer Prevention 2012; 13(2) doi: 10.7314/APJCP.2012.13.2.725
48
Oliver Clements, Joseph Eliahoo, Jin Un Kim, Simon D. Taylor-Robinson, Shahid A. Khan. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Journal of Hepatology 2020; 72(1) doi: 10.1016/j.jhep.2019.09.007
49
Tushar Patel. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. Journal of Gastroenterology 2014; 49(2) doi: 10.1007/s00535-013-0894-y
50
Chyng-Wen Fwu, Yin-Chu Chien, San-Lin You, Kenrad E. Nelson, Gregory D. Kirk, Hsu-Sung Kuo, Manning Feinleib, Chien-Jen Chen. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan. Hepatology 2011; 53(4) doi: 10.1002/hep.24150
51
Samuel O. Antwi, Omar Y. Mousa, Tushar Patel. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014. Annals of Hepatology 2018; 17(4) doi: 10.5604/01.3001.0012.0929
52
Jun Yan, Tatsuo Kanda, Shuang Wu, Fumio Imazeki, Osamu Yokosuka. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatology Research 2012; 42(10) doi: 10.1111/j.1872-034X.2012.01009.x
53
Yan Zhang, Zhuo Ying Li, Qiu Ming Shen, Jia Yi Tuo, Jing Yu Tan, Yu Ting Tan, Hong Lan Li, Yong Bing Xiang. A prospective cohort study of cigarette smoking, alcohol drinking and liver cancer incidence in Chinese men. Journal of Digestive Diseases 2022; 23(8-9) doi: 10.1111/1751-2980.13136
54
Ya-yong Li, Hao Li, Pin Lv, Gang Liu, Xiao-rong Li, Bu-ning Tian, Dao-jin Chen. Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment. Journal of Gastrointestinal Surgery 2011; 15(4) doi: 10.1007/s11605-011-1419-8
55
W. F. Shen, W. Zhong, Q. Liu, C. J. Sui, Y. Q. Huang, J. M. Yang. Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study. World Journal of Surgery 2011; 35(9) doi: 10.1007/s00268-011-1171-y
56
M. Tanaka, H. Tanaka, H. Tsukuma, A. Ioka, A. Oshima, T. Nakahara. Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. Journal of Viral Hepatitis 2010; 17(10) doi: 10.1111/j.1365-2893.2009.01243.x
57
Dietmar Tamandl, Beata Herberger, Birgit Gruenberger, Harald Puhalla, Markus Klinger, Thomas Gruenberger. Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology 2008; 15(10) doi: 10.1245/s10434-008-0081-1
58
Qiao Wu, Xiao-Dong He, Lan Yu, Wei Liu, Lian-Yuan Tao. The Metabolic Syndrome and Risk Factors for Biliary Tract Cancer: A Case-control Study in China. Asian Pacific Journal of Cancer Prevention 2012; 13(5) doi: 10.7314/APJCP.2012.13.5.1963
59
海玲 乔. Progress in Treatment of Unresectable Intrahepatic Cholangiocarcinoma. Advances in Clinical Medicine 2023; 13(12) doi: 10.12677/ACM.2023.13122790
60
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017;  doi: 10.1007/978-3-319-26956-6_31
61
Chia-Sheng Chu, Che-Chen Lin, Cheng-Yuan Peng, Po-Heng Chuang, Wen-Pang Su, Shih-Wei Lai, Hsuan-Ju Chen, Chi-Jung Chung, Hsueh-Chou Lai. Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?. Medicine 2017; 96(34) doi: 10.1097/MD.0000000000007785
62
Yan-Jiun Huang, Alexander TH Wu, Hung-Yi Chiou, Ming-Tsang Chuang, Tzu-Ching Meng, Li-Nien Chien, Yun Yen. Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control study. Oncotarget 2017; 8(4) doi: 10.18632/oncotarget.14254
63
Stefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, Francesco Vasuri, Julien Edeline, Deborah Malvi, Karim Boudjema, Matteo Renzulli, Heithem Jeddou, Antonietta D’Errico, Bruno Turlin, Matteo Cescon, Thomas Uguen, Alessandro Granito, Astrid Lièvre, Giovanni Brandi. Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role. Cancers 2020; 12(11) doi: 10.3390/cancers12113182
64
Yasuhiro Ito, Takeshi Kenmochi, Tomohisa Egawa, Shinobu Hayashi, Atsushi Nagashima, Yuko Kitagawa. Diagnosis of Distal Cholangiocarcinoma after the Removal of Choledocholithiasis. Gastroenterology Research and Practice 2012; 2012 doi: 10.1155/2012/396869
65
Chiara Braconi, Tushar Patel. Cholangiocarcinoma: New Insights into Disease Pathogenesis and Biology. Infectious Disease Clinics of North America 2010; 24(4) doi: 10.1016/j.idc.2010.07.006
66
Ethan Kai Jun Tham, Ryan Yanzhe Lim, Benjamin Koh, Darren Jun Hao Tan, Cheng Han Ng, Michelle Law, Elina Cho, Nicole Shu Ying Tang, Claire Shiying Tan, Benedix Kuan Loo Sim, En Ying Tan, Wen Hui Lim, Mei Chin Lim, Toru Nakamura, Pojsakorn Danpanichkul, Sakkarin Chirapongsathorn, Karn Wijarnpreecha, Hirokazu Takahashi, Asahiro Morishita, Ming-Hua Zheng, Alfred Kow, Mark Muthiah, Jia Hao Law, Daniel Q Huang. Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis. Clinical Gastroenterology and Hepatology 2025; 23(10) doi: 10.1016/j.cgh.2024.09.028
67
L. Zender, N. P. Malek. Diagnostik und Therapie des cholangiozellulären Karzinoms. Der Internist 2016; 57(12) doi: 10.1007/s00108-016-0128-5
68
Riham Katkhuda, Yun Shin Chun. Intrahepatic Cholangiocarcinoma. 2019;  doi: 10.1007/978-3-030-22258-1_1
69
Li Jiang, Li-Sheng Jiang, Lu-Nan Yan, Fu-Yu Li, Wei Wang, Nan-Sheng Cheng, Tian-Fu Wen. Effects of Epidermal Growth Factor Receptor Inhibitor Genistein on Proliferative Cholangitis in Rats. Journal of Surgical Research 2010; 162(1) doi: 10.1016/j.jss.2009.04.048
70
Jun-hua LU, Jing ZHANG, Guang-shun YANG, Jun ZHAO, Ning YANG, Hai-bin ZHANG, Chun-feng SHI, Tian YANG. Diagnosis and treatment of long-term hepatolithiasis associated with intrahepatic cholangiocarcinoma. Academic Journal of Second Military Medical University 2009; 28(9) doi: 10.3724/SP.J.1008.2008.01128
71
William C. Palmer, Tushar Patel. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. Journal of Hepatology 2012; 57(1) doi: 10.1016/j.jhep.2012.02.022
72
Ming‐Shian Tsai, Po‐Huang Lee, Cheng‐Li Lin, Chiao‐Ling Peng, Chia‐Hung Kao. Type II diabetes mellitus is associated with a reduced risk of cholangiocarcinoma in patients with biliary tract diseases. International Journal of Cancer 2015; 136(10) doi: 10.1002/ijc.29292
73
Elio Jovine, Annalisa Pession, Andrea Cuppini, Carlo Fabbri, Laura Pontoriero, Sergio Sabbatani, Michela Visani, Arrigo Bondi, Luca di Tommaso, Giorgia Acquaviva, Raffaele Lombardi, Laura Mastrangelo, Matteo Zanello, Fabio Grizzi, Andrea Tura, Michele Masetti, Adele Fornelli, Dario de Biase, Letizia Bacchi-Reggiani, Sirio Fiorino. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
74
Seogsong Jeong, Ying Tong, Meng Sha, Jinyang Gu, Qiang Xia. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget 2017; 8(10) doi: 10.18632/oncotarget.14079
75
Yong Eun Chung, Myeong-Jin Kim, Young Nyun Park, Jin-Young Choi, Ju Yeon Pyo, Young Chul Kim, Hyeon Je Cho, Kyung Ah Kim, Sun Young Choi. Varying Appearances of Cholangiocarcinoma: Radiologic-Pathologic Correlation. RadioGraphics 2009; 29(3) doi: 10.1148/rg.293085729
76
Yoshito Ikematsu, Tsutomu Tomioka, Tsukasa Tsunoda, Yoshitsugu Tajima, Takashi Kanematsu. Hepatobiliary and Pancreatic Carcinogenesis in the Hamster. 2009;  doi: 10.1007/978-4-431-87773-8_9
77
Murad Aljiffry, Mark J Walsh, Michele Molinari. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World Journal of Gastroenterology 2009; 15(34): 4240-4262 doi: 10.3748/wjg.15.4240
78
Emmanouil Sinakos, Christos Emmanouilides, Panteleimon Panas, Lazaros Sideras, Nikolaos Fragkou. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?. World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
79
Yan-Ming Zhou, Lu Cao, Bin Li, Xiu-Zhong Zhang, Zheng-Feng Yin. Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases International 2012; 11(5) doi: 10.1016/S1499-3872(12)60219-7
80
Men-Bao Qian, Ying-Dan Chen, Song Liang, Guo-Jing Yang, Xiao-Nong Zhou. The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma. Infectious Diseases of Poverty 2012; 1(1) doi: 10.1186/2049-9957-1-4
81
A. Shin, S. Park, H.R. Shin, E.-H. Park, S.K. Park, J.-K. Oh, M.-K. Lim, B.Y. Choi, M. Boniol, P. Boffetta. Population attributable fraction of infection-related cancers in Korea. Annals of Oncology 2011; 22(6) doi: 10.1093/annonc/mdq592
82
Lingyu Tian, Jiaqiang Ma, Lijie Ma, Bohao Zheng, Longzi Liu, Danjun Song, Yining Wang, Zhao Zhang, Qiang Gao, Kang Song, Xiaoying Wang. PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02082-5
83
Neil Bhardwaj, David M. Lloyd. Handbook of Gastrointestinal Cancer. 2012;  doi: 10.1002/9781118423318.ch8
84
Yuenan Huang, Liuping You, Weimin Xie, Li Ning, Jinghe Lang. Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(59) doi: 10.18632/oncotarget.20141
85
Aaron P. Thrift, Hashem B. El-Serag, Fasiha Kanwal. Global epidemiology and burden of HCV infection and HCV-related disease. Nature Reviews Gastroenterology & Hepatology 2017; 14(2) doi: 10.1038/nrgastro.2016.176
86
Lorenza Rimassa, Shahid Khan, Bas Groot Koerkamp, Stephanie Roessler, Jesper B. Andersen, Chiara Raggi, Ana Lleo, Jean-Charles Nault, Julien Calderaro, Chiara Gabbi, Jakob N. Kather, Jesus M. Banales, Irene Bargellini, Helen Morement, Marcin Krawczyk, Paraskevi A. Farazi, Guido Carpino, Matias A. Avila, Anna Saborowski, Vincenzo Cardinale, Chiara Braconi, Rocio I.R. Macias. Mapping the landscape of biliary tract cancer in Europe: challenges and controversies. The Lancet Regional Health - Europe 2025; 50 doi: 10.1016/j.lanepe.2024.101171
87
Tarun Rustagi, Constantin A. Dasanu. Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates. Journal of Gastrointestinal Cancer 2012; 43(2) doi: 10.1007/s12029-011-9284-y
88
P W Ewald. 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Symbionts and immunopathology in chronic diseases: insights from evolution. Clinical and Experimental Immunology 2010; 160(1) doi: 10.1111/j.1365-2249.2010.04127.x
89
Philipp Heumann, Andreas Albert, Karsten Gülow, Denis Tümen, Martina Müller, Arne Kandulski. Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma. Cancers 2024; 16(9) doi: 10.3390/cancers16091690
90
Yan-Ming Zhou, Jia-Mei Yang, Bin Li, Zheng-Feng Yin, Feng Xu, Bin Wang, Peng Liu, Zhi-Min Li. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein. World Journal of Gastroenterology 2008; 14(14): 2251-2254 doi: 10.3748/wjg.14.2251
91
Shinichi Aishima, Yuki Tanaka, Yuichiro Kubo, Ken Shirabe, Yoshihiko Maehara, Yoshinao Oda. Bile duct adenoma and von Meyenburg complex‐like duct arising in hepatitis and cirrhosis: Pathogenesis and histological characteristics. Pathology International 2014; 64(11) doi: 10.1111/pin.12209
92
Gia L. Tyson, Hashem B. El-Serag. Risk factors for cholangiocarcinoma. Hepatology 2011; 54(1) doi: 10.1002/hep.24351
93
Giuliana Cavalloni, Caterina Peraldo-Neia, Francesco Sassi, Giovanna Chiorino, Ivana Sarotto, Massimo Aglietta, Francesco Leone. Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2136-1
94
Rakesh Sahu, Praveen Sharma, Ajay Kumar. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment. Journal of Gastrointestinal Cancer 2023; 54(1) doi: 10.1007/s12029-021-00728-5
95
Mengge Li, Min Du, Hui Cong, Yuanyuan Gu, Yuan Fang, Jin Li, Yu Gan, Hong Tu, Jinyang Gu, Qiang Xia. Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma. Hepatology Research 2021; 51(1) doi: 10.1111/hepr.13580
96
John Bridgewater, Peter R. Galle, Shahid A. Khan, Josep M. Llovet, Joong-Won Park, Tushar Patel, Timothy M. Pawlik, Gregory J. Gores. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of Hepatology 2014; 60(6) doi: 10.1016/j.jhep.2014.01.021
97
Hao Liang, Jianbing Wang, Huijuan Xiao, Ding Wang, Wenqiang Wei, Youlin Qiao, Paolo Boffetta. Estimation of cancer incidence and mortality attributable to alcohol drinking in china. BMC Public Health 2010; 10(1) doi: 10.1186/1471-2458-10-730
98
Wei-Feng Shen, Wei Zhong, Feng Xu, Tong Kan, Li Geng, Feng Xie, Cheng-Jun Sui, Jia-Mei Yang. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2009; 15(47): 5976-5982 doi: 10.3748/wjg.15.5976
99
Maria-Cristina Navas, Shannon Glaser, Harshil Dhruv, Scott Celinski, Gianfranco Alpini, Fanyin Meng. Hepatitis C Virus Infection and Cholangiocarcinoma. The American Journal of Pathology 2019; 189(6) doi: 10.1016/j.ajpath.2019.01.018
100
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 2010; 42(4) doi: 10.1016/j.dld.2009.12.008
101
Alessandro De Santis, Lei Zhu, Jianxin Tao, Christoph Reißfelder, Sebastian Schölch. Molecular subtypes of intrahepatic cholangiocarcinoma. Trends in Molecular Medicine 2025; 31(8) doi: 10.1016/j.molmed.2025.01.008
102
Zhen-Yu Liu, Yan-Ming Zhou, Le-Hua Shi, Zheng-Feng Yin. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. Hepatobiliary & Pancreatic Diseases International 2011; 10(6) doi: 10.1016/S1499-3872(11)60106-9
103
Li Bai, Li Ren, Mei Xiong, Guang-Qing Zhu, Zhi-Yuan Mao. Prognostic value of neutrophil distribution in cholangiocarcinoma. World Journal of Gastroenterology 2015; 21(16): 4961-4968 doi: 10.3748/wjg.v21.i16.4961
104
Sang Hoon Lee, Seung Woo Park. Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer. The Korean Journal of Gastroenterology 2015; 66(6) doi: 10.4166/kjg.2015.66.6.325
105
Yufei Zhu, Yunhai Zhu, Feng Cai, Jie Zhao, Feng Liu. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma. Cell Biochemistry and Biophysics 2015; 73(2) doi: 10.1007/s12013-015-0665-x
106
Shinichi Aishima, Nobuhiro Fujita, Yohei Mano, Tomohiro Iguchi, Akinobu Taketomi, Yoshihiko Maehara, Yoshinao Oda, Masazumi Tsuneyoshi. p62+ Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated With Viral Hepatitis or Alcoholic Liver Disease. American Journal of Clinical Pathology 2010; 134(3) doi: 10.1309/AJCP53YVVJCNDZIR
107
Ankitha Sivanand, Durva Talati, Yash Kalariya, Priyansh Patel, Siddharth Kamal Gandhi. Associations of Liver Fluke Infection and Cholangiocarcinoma: A Scoping Review. Cureus 2023;  doi: 10.7759/cureus.46400
108
Paul W. Ewald. Natural History of Host-Parasite Interactions. Advances in Parasitology 2009; 68 doi: 10.1016/S0065-308X(08)00602-7
109
C H Lee, C J Chang, Y J Lin, C N Yeh, M F Chen, S Y Hsieh. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. British Journal of Cancer 2009; 100(11) doi: 10.1038/sj.bjc.6605063
110
Samuel O. Antwi, Omar Y. Mousa, Tushar Patel. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014. Annals of Hepatology 2018; 17(2) doi: 10.5604/01.3001.0010.8659
111
Di Sun, Min Ding, Mengfan Ruan, Li Yang, Xingshun Qi. Hepatitis C - Recent Advances. 2023;  doi: 10.5772/intechopen.1001335
112
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016;  doi: 10.1007/978-3-319-26587-2_31-1
113
Hogil Kim, Yun Kyung Chung, Inah Kim. Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea. Annals of Occupational and Environmental Medicine 2018; 30(1) doi: 10.1186/s40557-018-0217-0
114
Lei Zhang, Jian‐Qiang Cai, Jian‐Jun Zhao, Xin‐Yu Bi, Xiao‐Gang Tan, Tao Yan, Cong Li, Ping Zhao. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 2010; 101(3) doi: 10.1002/jso.21488
115
Masakazu Yamamoto, Shun-ichi Ariizumi. Surgical outcomes of intrahepatic cholangiocarcinoma. Surgery Today 2011; 41(7) doi: 10.1007/s00595-011-4517-z
116
Paul W. Ewald, Holly A. Swain Ewald. . Advances in Parasitology 2014; 84 doi: 10.1016/B978-0-12-800099-1.00001-6
117
Sergio Hoyos, Maria-Cristina Navas, Juan-Carlos Restrepo, Rafael Claudino Botero. Current controversies in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4) doi: 10.1016/j.bbadis.2017.07.027
118
D Tamandl, K Kaczirek, B Gruenberger, C Koelblinger, J Maresch, R Jakesz, T Gruenberger. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. British Journal of Surgery 2009; 96(8) doi: 10.1002/bjs.6654
119
Dong Kuang, Guo-Ping Wang. Hilar cholangiocarcinoma: Pathology and tumor biology. Frontiers of Medicine in China 2010; 4(4) doi: 10.1007/s11684-010-0130-6
120
Nataliya Razumilava, Gregory J Gores. Cholangiocarcinoma. The Lancet 2014; 383(9935) doi: 10.1016/S0140-6736(13)61903-0
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.